IBO Total Utang marang Modal Impact BioMedical

Impact BioMedical Inc (IBO) is a diversified biotech holding company whose strategy relies on a broad spectrum of developments, creating risks due to resource dilution. This chart on GURU.Markets tracks the asset value at 0.00, while a lack of sales leaves the company dependent on patent valuations. Geopolitical tensions further complicate the situation, hindering drug exports and disrupting raw material supplies.

IBO Rasio Kabeh Utang marang Dana Pribadi Impact BioMedical (17.09.2024 - 28.10.2026)

Rincian analitis perusahaan Impact BioMedical Inc

- rega lan prakiraan konsensus rega:
Rega saham Impact BioMedical Inc|IBO - Konsensus nilai wajar
- data kapitalisasi pasar:
Kapitalisasi pasar Impact BioMedical|IBO - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Impact BioMedical|IBO - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku impactbiomedinc.com|IBO - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Impact BioMedical Inc|IBO - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Impact BioMedical|IBO - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Impact BioMedical|IBO - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Impact BioMedical
Ringkesan analisis perusahaan:Impact BioMedical Inc IBO

The total debt-to-equity ratio measures the degree of financial leverage by comparing total liabilities to equity to assess a business's dependence on external borrowing. Amidst an R&D lull, the current leverage ratio of Impact BioMedical Inc (IBO) reflects the resilience of its balance sheet structure in the absence of active operational cash flow, determining the extent to which assets are protected from credit risks.

Analisis perusahaan pesaing

HLN - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Kenvue Inc|Total Utang marang Modal VRNA|Total Utang marang Modal MENS (Jyong Bio)|Utang marang Ekuitas Ligand Pharmaceuticals|amneal.com - Rasio Kabeh Utang marang Dana Pribadi|PRGO: Utang marang Ekuitas|ALVO - Rasio Total Utang marang Ekuitas|LQDA: Total Utang marang Modal|Total Utang marang Modal Galapagos Corp|ANIP - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi MNKD|Amphastar Pharmaceuticals, Inc. - Utang marang Ekuitas|Utang marang Modal Pacira Pharmaceuticals PCRX|Rasio Total Utang marang Ekuitas ARS Pharma (SPRY)|Utang Agregat marang Modal Theravance Corp TBPH|Total Utang marang Modal Aquestive Therapeutics (AQST)|SCPH - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal TECX|TNXP (Tonix Pharma) - Utang marang Modal|SXTC - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Eupraxia Pharma|BHST (BioHarvest Sciences) - Total Utang marang Modal|Koefisien Total Utang marang Modal EXOZ (invizyne.com)|Oramed Pharmaceuticals Inc. - Utang marang Ekuitas|Entera Bio Ltd - Rasio Total Utang marang Ekuitas|Utang marang Ekuitas MindWalk|ABVC - Utang Agregat marang Ekuitas|CPIX: Total Utang marang Modal|quantumbiopharma.com (QNTM) - Total Utang marang Modal|Total Utang marang Modal FGEN|Rasio Total Utang marang Ekuitas Telomir Pharmaceuticals Inc (TELO)|Rasio Total Utang marang Ekuitas Rani Therapeutics|Utang Agregat marang Modal synergychc.com SNYR|Rasio Total Utang marang Ekuitas Rallybio|Rasio Kabeh Utang marang Dana Pribadi Lexaria Bioscience Corp LEXX|PULM - Total Utang marang Modal|PTHL - Utang marang Ekuitas|aptorumgroup.com - Total Utang marang Modal|LYRA (Lyra Therapeutics Inc) - Koefisien Total Utang marang Modal|Utang marang Ekuitas TNFA (TNF Pharmaceuticals Inc.)|Utang marang Modal YCBD|Utang marang Ekuitas PRFX (PainReform)|Rasio Total Utang marang Ekuitas altamiratherapeutics.com (CYTO)|LIPO: Total Utang marang Modal|Utang marang Modal OptiNose Corp OPTN|Pieris Pharmaceuticals (PIRS) - Total Utang marang Modal|PROC - Rasio Utang marang Ekuitas|Petros Pharmaceuticals, Inc. - Total Utang marang Modal|Qilian International Holding Group (QLI) - Koefisien Total Utang marang Modal|Total Utang marang Modal SLRN|Rasio Total Utang marang Ekuitas TFF Pharmaceuticals, Inc